- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Myeloma and Waldenström macroglobulinemia Co-Pay Funding Announced
Effective February 1, 2010, eligible myeloma and Waldenström macroglobulinemia patients will now be able to receive up to $10,000 in support to help offset the costs of prescription drug co-pays and other insurance related expenses.
Patients, caregivers and healthcare professionals may submit patient applications easily online through the established link on the Co-Pay webpage www.lls.org/copay. Applications can also be submitted on the toll-free line with a Co-Pay specialist. Eligibility will be determined by medical and financial need.
The Leukemia & Lymphoma Society's (LLS) Co-Pay Assistance Program offers assistance to patients toward:
• Cancer treament related co-pays
• Private health insurance premiums
• Private insurance co-pay obligations
• Medicare Part B, Medicare Plan D, Medicare Supplementary Health Insurance and Medicare Advantage premium or co-pay obligations
For more information on this and other LLS Co-Pay Assistance Program disease funds, please call 877-557-2672 or visit www.lls.org/copay.
• Chronic myelogenous leukemia-assistance is available up to $5,000
• Chronic lymphocytic leukemia-assistance is available up to $5,000
• Hodgkin lymphoma- assistance is available up to $5,000
• Non-Hodgkin lymphoma -assistance is available up to $5,000
• Myelodysplastic syndromes (MDS)-assistance is available up to $5,000
• Myeloma -assistance is available up to $10,000
• Waldenstrom macroglobulinemia -assistance is available up to $10,000